Dishman Carbogen Amcis Profile
Key Indicators
- Authorised Capital ₹ 34.05 Cr
as on 15-11-2024
- Paid Up Capital ₹ 31.36 Cr
as on 15-11-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1,690.18 Cr
as on 15-11-2024
- Satisfied Charges ₹ 665.07 Cr
as on 15-11-2024
- Revenue 23.39%
(FY 2023)
- Profit -86.59%
(FY 2023)
- Ebitda -77.30%
(FY 2023)
- Net Worth -2.78%
(FY 2023)
- Total Assets -0.64%
(FY 2023)
About Dishman Carbogen Amcis
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540701 and on the National Stock Exchange(NSE) under DCAL.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 34.05 Cr and a paid-up capital of Rs 31.36 Cr.
The company currently has active open charges totaling ₹1,690.18 Cr. The company has closed loans amounting to ₹665.07 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dishman Carbogen Amcis Limited India are Harshil Dalal as CFO and Shrima Dave as Company Secretary. Janmejay Vyas, Subir Das, Maitri Mehta, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dishman Carbogen Amcis?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Harshil Dalal | CFO | 28-Nov-2018 | Current |
Shrima Dave | Company Secretary | 17-Mar-2017 | Current |
Arpit Vyas | Managing Director | 07-Apr-2012 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Subir Das | Director | 17-Mar-2017 | Current |
Rajendra Shah | Director | 17-Mar-2017 | Current |
Janmejay Vyas | Director | 17-Jul-2007 | Current |
Maitri Mehta | Director | 01-Apr-2019 | Current |
Deohooti Vyas | Whole-Time Director | 17-Mar-2017 | Current |
Financial Performance and Corporate Structure Insights of Dishman Carbogen Amcis.
Dishman Carbogen Amcis Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.39% increase. The company also saw a substantial fall in profitability, with a 86.59% decrease in profit. The company's net worth dipped by a decrease of 2.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dishman Carbogen Amcis?
In 2022, Dishman Carbogen Amcis had a promoter holding of 59.32% and a public holding of 40.67%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dishman Biotech LimitedActive 29 years 1 month
Janmejay Vyas, Arpit Vyas and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 16 Sep 2024 | ₹25.00 Cr | Open |
Others Creation Date: 01 Jun 2024 | ₹75.00 Cr | Open |
Others Creation Date: 29 Dec 2023 | ₹75.00 Cr | Open |
How Many Employees Work at Dishman Carbogen Amcis?
Unlock and access historical data on people associated with Dishman Carbogen Amcis, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dishman Carbogen Amcis, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dishman Carbogen Amcis's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.